Patients—visual analysis results for GMCa
| Model | Potentially Epileptogenic (and Visible) | Potentially Epileptogenic (and Not Visible) | Potentially Epileptogenic (Combined) | Nonepileptogenic | Unclear | Artifacts |
|---|---|---|---|---|---|---|
| Concordant lobe (%) | ||||||
| T1 | 15.4 | 15.4 | 30.8 | 7.7 | 15.4 | 0 |
| T1+T2 | 15.4 | 0 | 15.4 | 7.7 | 15.4 | 0 |
| T1+FLAIR | 15.4 | 30.8 | 46.2 | 7.7 | 23.1 | 0 |
| T1+T2+FLAIR | 15.4 | 15.4 | 30.8 | 7.7 | 23.1 | 0 |
| Discordant lobe (%) | ||||||
| T1 | 7.7 | 38.5 | 46.2 | 7.7 | 30.8 | 15.4 |
| T1+T2 | 7.7 | 23.1 | 30.8 | 0 | 23.1 | 0 |
| T1+FLAIR | 7.7 | 30.8 | 38.5 | 7.7 | 30.8 | 7.7 |
| T1+T2+FLAIR | 7.7 | 23.1 | 30.8 | 0 | 30.8 | 7.7 |
↵a Visual interpretation results of GMC analysis of patients are provided. The results contain percentages of patients scored by the reviewer as potentially epileptogenic and visible, potentially epileptogenic and not visible, potentially epileptogenic (number of patients with potentially epileptogenic and visible/not visible or both), nonepileptogenic, unclear, and artifacts. The results are reported for both concordant and discordant lobes.